Providing reproductive health services for women who inject drugs: a pilot program.
Needle syringe programs
Reproductive health
Substance use disorder
Syringe exchange programs
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
14 07 2020
14 07 2020
Historique:
received:
17
06
2019
accepted:
03
07
2020
entrez:
16
7
2020
pubmed:
16
7
2020
medline:
13
7
2021
Statut:
epublish
Résumé
Needle syringe programs (NSPs), a proven harm reduction strategy for people who inject drugs, frequently offer limited healthcare services for their clients. Women who inject drugs face multiple barriers to accessing reproductive health care in traditional settings: personal histories of trauma, judgmental treatment from providers, and competing demands on their time. Our aim was to implement patient-centered reproductive healthcare services at a Seattle NSP. We interviewed clients and staff of an NSP in Seattle and staff of other community-based organizations serving women who inject drugs, then used the Consolidated Framework for Implementation Research to code transcripts deductively. Based on our qualitative work, we implemented reproductive health care at the NSP program 1 day per week. We evaluated the implementation by surveying staff and clients and auditing charts over a 9-month period. Clients and staff (N = 15 for clients, N = 13 for staff) noted a high unmet need for trauma-informed, accessible reproductive health care. We successfully implemented reproductive health care services including short- and long-acting contraception, sexually transmitted disease testing, and cervical cancer screening. Survey data was limited but demonstrated client satisfaction with services. Integrating reproductive health care into an NSP's clinical services is feasible and can be a source of low-barrier preventive care for women unable to seek gynecologic care elsewhere.
Sections du résumé
BACKGROUND
Needle syringe programs (NSPs), a proven harm reduction strategy for people who inject drugs, frequently offer limited healthcare services for their clients. Women who inject drugs face multiple barriers to accessing reproductive health care in traditional settings: personal histories of trauma, judgmental treatment from providers, and competing demands on their time. Our aim was to implement patient-centered reproductive healthcare services at a Seattle NSP.
METHODS
We interviewed clients and staff of an NSP in Seattle and staff of other community-based organizations serving women who inject drugs, then used the Consolidated Framework for Implementation Research to code transcripts deductively. Based on our qualitative work, we implemented reproductive health care at the NSP program 1 day per week. We evaluated the implementation by surveying staff and clients and auditing charts over a 9-month period.
RESULTS
Clients and staff (N = 15 for clients, N = 13 for staff) noted a high unmet need for trauma-informed, accessible reproductive health care. We successfully implemented reproductive health care services including short- and long-acting contraception, sexually transmitted disease testing, and cervical cancer screening. Survey data was limited but demonstrated client satisfaction with services.
CONCLUSIONS
Integrating reproductive health care into an NSP's clinical services is feasible and can be a source of low-barrier preventive care for women unable to seek gynecologic care elsewhere.
Identifiants
pubmed: 32664931
doi: 10.1186/s12954-020-00395-y
pii: 10.1186/s12954-020-00395-y
pmc: PMC7362507
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
47Références
PLoS One. 2014 May 19;9(5):e97596
pubmed: 24840662
Prev Med. 2015 Nov;80:23-31
pubmed: 25900803
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
Health Aff (Millwood). 2010 May;29(5):914-20
pubmed: 20439880
Psychol Addict Behav. 2011 Jun;25(2):194-205
pubmed: 21443291
Health Aff (Millwood). 2010 Oct;29(10):1834-41
pubmed: 20921483
MMWR Morb Mortal Wkly Rep. 2010 Nov 19;59(45):1488-91
pubmed: 21085091
Subst Use Misuse. 2001 May-Jun;36(6-7):807-24
pubmed: 11697612
Subst Use Misuse. 2006;41(6-7):777-813
pubmed: 16809167
MMWR Recomm Rep. 2016 Jul 29;65(4):1-66
pubmed: 27467319
J Am Board Fam Med. 2013 Sep-Oct;26(5):539-57
pubmed: 24004706
Soc Sci Med. 2014 Apr;106:151-8
pubmed: 24561777
J Adolesc Health. 2017 Mar;60(3S):S30-S37
pubmed: 28235433
Lancet. 2018 Jun 30;391(10140):2642-2692
pubmed: 29753597
Int J Drug Policy. 2016 Jan;27:138-45
pubmed: 26394538
Int J Drug Policy. 2018 Jul;57:104-110
pubmed: 29715589
Crit Care Med. 2017 May;45(5):899-906
pubmed: 28234753
Subst Use Misuse. 1999 Mar-Apr;34(4-5):727-46
pubmed: 10210102
Soc Sci Med. 2005 Jul;61(1):171-83
pubmed: 15847970
Am J Public Health. 2012 Oct;102(10):1833-6
pubmed: 22897527
J Urban Health. 2002 Dec;79(4):586-99
pubmed: 12468678
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Am J Drug Alcohol Abuse. 2005;31(3):371-91
pubmed: 16161724
Aust N Z J Obstet Gynaecol. 2012 Apr;52(2):146-50
pubmed: 22335489